Utilization of Gonadotropin-Releasing Hormone Agonists in the Treatment of Metastatic and Locally Advanced Prostate Cancer - Comparisons of Practices from Three European Countries Cover

.blurhash-client-img { display: none !important; }

Utilization of Gonadotropin-Releasing Hormone Agonists in the Treatment of Metastatic and Locally Advanced Prostate Cancer - Comparisons of Practices from Three European Countries

EABR. Experimental and Applied Biomedical Research

By: Ivan Milovanović, Filip Milutinović, Đorđe Đorđević, Filip Mihajlović, Vladimir Bančević and Dragan Milovanović

Open Access

|Jun 2022

DOI: https://doi.org/10.2478/sjecr-2021-0070 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454

Journal RSS Feed

Language: English

Submitted on: Nov 8, 2021

Accepted on: Dec 27, 2021

Published on: Jun 8, 2022

Published by: University of Kragujevac, Faculty of Medical Sciences

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

prostatic neoplasms,

ATC/DDD metholology,

drug utilization

Related subjects:

Clinical medicine,

Clinical medicine, other

© 2022 Ivan Milovanović, Filip Milutinović, Đorđe Đorđević, Filip Mihajlović, Vladimir Bančević, Dragan Milovanović, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.